经验证瘙痒评估工具在皮肤科诊室与门诊的可接受性和感知获益:患者与医生视角
该研究在德国10家皮肤科诊室和2家皮肤科门诊招募523例慢性瘙痒患者,评估经验证患者报告结局测量工具(PROMs)的可接受性和感知获益。患者对PROMs可接受性高,医生认为瘙痒强度数值评定量表(NRS)最有获益。仅招募地点与医生报告的有用性和可行性显著相关。
要点
- 慢性瘙痒患者对经验证PROMs可接受性高,完成难度低且相关性高。
- 医生认为NRS是临床常规中最有获益的瘙痒评估工具。
- 招募地点(诊室 vs 门诊)与医生报告的有用性和可行性显著相关。
核心结论
- 患者欢迎PROMs用于临床实践,医生认为测量瘙痒强度和生活质量受损的工具对临床常规有益。
研究设计与样本
- 在德国10家皮肤科诊室和2家皮肤科门诊招募523例因特应性皮炎、银屑病、慢性痒疹或慢性荨麻疹导致的慢性瘙痒患者。
- 患者完成经验证PROMs,包括瘙痒强度NRS、症状控制ItchCD、生活质量DLQI和5PLQ、一般健康状况EQ-VAS。
- 患者和医生分别用NRS(0-10)评估这些工具的可接受性和获益,数据描述性分析,线性回归研究年龄、性别、职业、诊室vs门诊、治疗改变与医生报告获益的关联。
主要发现
- 患者对PROMs可接受性高,所有PROMs完成难度中位数=0(IQR=0-1),相关性中位数=8(IQR=4-10)。
- 大多数患者(89-95%)认为问卷长度「正好合适」。
- 医生将NRS评为最有获益的工具(可行性:中位数=8,IQR=6-10;有用性:中位数=9,IQR=7-10)。
- 分层线性回归显示仅招募地点(皮肤科诊室vs门诊)与有用性和可行性显著相关(临床环境评分更高;βs=0.149-0.258,ps<0.05;EQ5d可行性除外,β=ns)。
临床怎么用
- 在皮肤科日常临床工作中广泛实施PROMs以改善慢性瘙痒患者的护理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Several patient-reported outcome measures (PROMs) have been developed for research to assess the multiple dimensions of chronic pruritus (CP). The acceptability and perceived benefits of their use in clinical practice remain unknown. OBJECTIVES: To assess the acceptability and perceived benefits of validated PROMs from the perspective of patients and physicians in dermatological offices and clinics. METHODS: Patients with CP due to atopic dermatitis, psoriasis, chronic prurigo or chronic urticaria were recruited at 10 dermatological offices and two dermatological clinics in Germany. Patients completed a set of validated PROMs on pruritus intensity (numerical rating scale, NRS), symptom control (itch-controlled days, ItchCD), quality of life (Dermatology Life Quality Index, DLQI; 5-pruritus life quality, 5PLQ) and general health status (EuroQol, EQ-VAS). Acceptability (relevance, difficulty of completion, length) and benefits (usefulness, feasibility) of these tools were assessed on a NRS (0-10) by patients and physicians, respectively. Data were analysed descriptively. Linear regression was used to study potential associations between age, sex, occupation, office versus clinic, change of therapy and physician-reported benefits. RESULTS: N = 523 patients (46% male, average age: 53.5 years) participated. Acceptability of PROMs by patients was high, indicated by low difficulty (Md = 0, IQR = 0-1 for all PROMs) and high relevance (Md = 8, IQR = 4-10 for all PROMs). Also, most patients (89-95%) rated length of the questionnaires as 'exactly right'. Physicians rated the NRS as the most beneficial instrument (feasibility: Md = 8, IQR = 6-10; usefulness: Md = 9, IQR = 7-10). Hierarchical linear regression revealed that only recruitment site (dermatological office vs. clinic) was significantly associated with usefulness and feasibility (higher ratings for clinical context; βs = 0.149-0.258, ps <0.05; except feasibility for EQ5d, β = ns). CONCLUSIONS: PROMs are welcomed by patients, while physicians consider instruments measuring pruritus intensity and impairment of quality of life as beneficial for the clinical routine. Widespread implementation of PROMs in daily clinical work is needed to improve care.
引用
- Pereira MP, Zeidler C, Szymczak H, et al. Acceptability and perceived benefits of validated pruritus assessment instruments in the dermatological office and clinic: The perspectives of patients and physicians. J Eur Acad Dermatol Venereol. 2024. PMID: 38975785. doi:10.1111/jdv.20148
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。